H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-01-09 AccNo: 0001144204-18-001468 Size: 66 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2017-12-26 AccNo: 0001144204-17-065176 Size: 54 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 内部交易: 2017-11-27,COO,Capponi Vincent ,卖出,4000普通股, $7.00
$Cytosorbents Corporation(CTSO)$ 内部交易: 2017-11-27,COO,Capponi Vincent ,期权,4000普通股, $4.20
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001144204-17-057871 Size: 162 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-09 AccNo: 0001144204-17-057745 Size: 4 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2017-11-09 盘后 披露财报,预期EPS -0.08 网页链接
$Cytosorbents Corporation(CTSO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-09-26 AccNo: 0001144204-17-049552 Size: 259 KB 网页链接
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2017-08-09 AccNo: 0001144204-17-041302 Size: 147 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-07 AccNo: 0001144204-17-040844 Size: 3 MB 网页链接